CA
PBYI icon

Commerzbank Aktiengesellschaft’s Puma Biotechnology PBYI Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,230
Closed -$260K – 1161
2015
Q2 		$260K Buy
2,230
+1,366
+158% +$247K ﹤0.01% 1086
2015
Q1 		$204K Buy
+864
New +$185K ﹤0.01% 1086

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Commerzbank Aktiengesellschaft's PBYI Position: Q3 2015 in Review

Commerzbank Aktiengesellschaft sold out of Puma Biotechnology (PBYI) in Q3 2015, closing a stake of 2,230 shares — an estimated $260K sold.

Commerzbank Aktiengesellschaft first reported a position in PBYI in Q1 2015 and held it in 2 quarters. The position peaked at $260K in Q2 2015. 163 funds tracked by Wall St. Rank hold PBYI as of Q3 2015.

  • Commerzbank Aktiengesellschaft reported no remaining Puma Biotechnology position as of Q3 2015 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 2,230 Puma Biotechnology shares in Q3 2015, an estimated $260K.
  • Commerzbank Aktiengesellschaft first reported a position in Puma Biotechnology in Q1 2015 and held it in 2 quarters.
  • Commerzbank Aktiengesellschaft's Puma Biotechnology position peaked at $260K in Q2 2015.
  • 163 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2015.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2015, filed 29 Oct 2015.